JP2006516098A5 - - Google Patents

Download PDF

Info

Publication number
JP2006516098A5
JP2006516098A5 JP2004562249A JP2004562249A JP2006516098A5 JP 2006516098 A5 JP2006516098 A5 JP 2006516098A5 JP 2004562249 A JP2004562249 A JP 2004562249A JP 2004562249 A JP2004562249 A JP 2004562249A JP 2006516098 A5 JP2006516098 A5 JP 2006516098A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
iia1
amino acid
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004562249A
Other languages
English (en)
Japanese (ja)
Other versions
JP4741242B2 (ja
JP2006516098A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038172 external-priority patent/WO2004056308A2/en
Publication of JP2006516098A publication Critical patent/JP2006516098A/ja
Publication of JP2006516098A5 publication Critical patent/JP2006516098A5/ja
Application granted granted Critical
Publication of JP4741242B2 publication Critical patent/JP4741242B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2004562249A 2002-11-26 2003-11-26 新脈管形成を調節するα５β１インテグリンへのキメラ及びヒト化抗体 Expired - Lifetime JP4741242B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42974302P 2002-11-26 2002-11-26
US60/429,743 2002-11-26
PCT/US2003/038172 WO2004056308A2 (en) 2002-11-26 2003-11-26 CHIMERIC AND HUMANIZED ANTIBODIES TO α5β1 INTEGRIN THAT MODULATE ANGIOGENESIS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011000939A Division JP2011120593A (ja) 2002-11-26 2011-01-06 新脈管形成を調節するα５β１インテグリンへのキメラ及びヒト化抗体

Publications (3)

Publication Number Publication Date
JP2006516098A JP2006516098A (ja) 2006-06-22
JP2006516098A5 true JP2006516098A5 (https=) 2006-11-02
JP4741242B2 JP4741242B2 (ja) 2011-08-03

Family

ID=32681936

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004562249A Expired - Lifetime JP4741242B2 (ja) 2002-11-26 2003-11-26 新脈管形成を調節するα５β１インテグリンへのキメラ及びヒト化抗体
JP2011000939A Pending JP2011120593A (ja) 2002-11-26 2011-01-06 新脈管形成を調節するα５β１インテグリンへのキメラ及びヒト化抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011000939A Pending JP2011120593A (ja) 2002-11-26 2011-01-06 新脈管形成を調節するα５β１インテグリンへのキメラ及びヒト化抗体

Country Status (14)

Country Link
EP (2) EP2351583A1 (https=)
JP (2) JP4741242B2 (https=)
KR (2) KR20050089151A (https=)
CN (1) CN100369930C (https=)
AU (1) AU2003298783B2 (https=)
BR (1) BR0316670A (https=)
CA (1) CA2507099C (https=)
ES (1) ES2387985T3 (https=)
MX (1) MXPA05005558A (https=)
NO (1) NO20053101L (https=)
NZ (1) NZ540562A (https=)
RU (1) RU2346701C2 (https=)
WO (1) WO2004056308A2 (https=)
ZA (1) ZA200505114B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ535425A (en) 2002-03-13 2008-05-30 Biogen Idec Inc Anti-alphavbeta6 antibodies
US7276589B2 (en) 2002-11-26 2007-10-02 Pdl Biopharma, Inc. Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
DK1755659T3 (da) * 2004-03-24 2012-02-27 Abbott Biotherapeutics Corp Anvendelse af anti-alfa5beta1-antistoffer til inhibering af kræftcelleproliferation
US20060008415A1 (en) * 2004-06-25 2006-01-12 Protein Design Labs, Inc. Stable liquid and lyophilized formulation of proteins
CN104072614B (zh) * 2005-07-08 2017-04-26 生物基因Ma公司 抗-αvβ6 抗体及其用途
NZ615012A (en) * 2006-03-21 2015-11-27 Genentech Inc Combinatorial therapy involving alpha5beta1 antagonists
ZA200807754B (en) * 2006-03-21 2009-12-30 Genentech Inc Combinatorial therapy involving alpha5beta1 antagonists
EA200802348A1 (ru) * 2006-05-24 2009-08-28 Байер Шеринг Фарма Акциенгезельшафт ЧЕЛОВЕЧЕСКИЙ ВЫСОКОАФФИННЫЙ И ГУМАНИЗИРОВАННЫЙ АНТИ-α5β1 ИНТЕГРИН С ФУНКЦИЕЙ БЛОКИРУЮЩЕГО АНТИТЕЛА С ОСЛАБЛЕННОЙ ИММУНОГЕННОСТЬЮ
CN101563105B (zh) 2006-07-10 2013-01-23 拜奥根Idec马萨诸塞公司 用于抑制smad4-缺陷癌症的组合物和方法
WO2009010290A2 (en) * 2007-07-17 2009-01-22 Merck Patent Gmbh Engineered anti-alpha v- integrin hybrid antibodies
WO2009018226A2 (en) * 2007-07-27 2009-02-05 Facet Biotech Corporation Pharmaceutical combinations comprising a tyrosine kinase inhibitor and an antibody against integrin alpha 1 beta 5 (cd49e)
MY151191A (en) * 2007-09-26 2014-04-30 Genentech Inc Novel antibodies
EP2650017A3 (en) 2008-02-05 2014-01-22 Bristol-Myers Squibb Company Alpha 5 - beta 1 antibodies and their uses
KR101054725B1 (ko) * 2008-07-31 2011-08-05 재단법인서울대학교산학협력재단 세포외기질 성분을 함유하는 노화조절용 조성물 및 이를이용한 노화세포의 노화조절방법
CA2748158A1 (en) 2008-12-23 2010-07-01 Astrazeneca Ab Targeted binding agents directed to .alpha.5.beta.1 and uses thereof
CA2748161A1 (en) * 2008-12-23 2010-07-01 Astrazeneca Ab Targeted binding agents directed to .alpha.5.beta.1 and uses thereof
CN102421800A (zh) * 2009-02-23 2012-04-18 格兰马克药品股份有限公司 结合cd19的人源化抗体及其用途
NZ594343A (en) * 2009-03-25 2013-10-25 Genentech Inc Novel anti-alpha5beta1 antibodies and uses thereof
CN101638429B (zh) * 2009-08-28 2012-01-25 南方医科大学 一种特异性识别细胞表面整合素α3β1的小分子肽
ES2982297T3 (es) * 2009-12-18 2024-10-15 Novartis Ag Método de cromatografía de afinidad
CA2790866C (en) * 2010-02-23 2019-02-12 Sanofi Anti-alpha2 integrin antibodies and their uses
CA2827052C (en) 2011-02-11 2022-08-16 Merck Patent Gmbh Anti-alpha-v integrin antibody for the treatment of prostate cancer
WO2013150043A1 (en) * 2012-04-05 2013-10-10 F. Hoffmann-La Roche Ag Bispecific antibodies against human tweak and human il17 and uses thereof
WO2014105910A1 (en) 2012-12-26 2014-07-03 Oncosynergy, Inc. ANTI- INTEGRIN β1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
WO2014144466A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof
WO2014143739A2 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof
EP4732889A2 (en) 2017-06-07 2026-04-29 Supira Medical, Inc. Intravascular fluid movement devices, systems, and methods of use
US11511103B2 (en) 2017-11-13 2022-11-29 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
JP7410034B2 (ja) 2018-02-01 2024-01-09 シファメド・ホールディングス・エルエルシー 血管内血液ポンプならびに使用および製造の方法
WO2020028537A1 (en) 2018-07-31 2020-02-06 Shifamed Holdings, Llc Intravascaular blood pumps and methods of use
WO2020073047A1 (en) 2018-10-05 2020-04-09 Shifamed Holdings, Llc Intravascular blood pumps and methods of use
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4010046A4 (en) 2019-08-07 2023-08-30 Calomeni, Michael Catheter blood pumps and collapsible pump housings
EP4034192B1 (en) 2019-09-25 2025-12-24 Supira Medical, Inc. Intravascular blood pump systems and methods of use and control thereof
WO2021062260A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Catheter blood pumps and collapsible blood conduits
EP4034221B1 (en) 2019-09-25 2024-11-13 Shifamed Holdings, LLC Catheter blood pumps and collapsible pump housings
EP4072650A4 (en) 2019-12-11 2024-01-10 Shifamed Holdings, LLC Descending aorta and vena cava blood pumps
US12599758B2 (en) 2019-12-19 2026-04-14 Shifamed Holdings, Llc Intravascular blood pumps, motors, and fluid control

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4704366A (en) * 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4801687A (en) * 1986-10-27 1989-01-31 Bioprobe International, Inc. Monoclonal antibody purification process using protein A
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
CA2082160C (en) 1991-03-06 2003-05-06 Mary M. Bendig Humanised and chimeric monoclonal antibodies
EP0519596B1 (en) 1991-05-17 2005-02-23 Merck & Co. Inc. A method for reducing the immunogenicity of antibody variable domains
EP0666923A1 (en) 1991-09-05 1995-08-16 The University Of Connecticut Targeted delivery of poly- or oligonucleotides to cells
AU669124B2 (en) 1991-09-18 1996-05-30 Kyowa Hakko Kirin Co., Ltd. Process for producing humanized chimera antibody
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
GB9125979D0 (en) 1991-12-06 1992-02-05 Wellcome Found Antibody
CA2130436C (en) 1992-02-19 2001-04-10 John S. Abrams Cloning and expression of humanized monoclonal antibodies against human interleukin-4
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
EP0745134A1 (en) 1994-02-22 1996-12-04 Danafarber Cancer Institute Nucleic acid delivery system, method of synthesis and uses thereof
US5705154A (en) 1995-03-08 1998-01-06 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
WO1999058139A2 (en) * 1998-05-08 1999-11-18 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis
US6852318B1 (en) * 1998-05-08 2005-02-08 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis
US7285268B2 (en) * 2002-11-26 2007-10-23 Pdl Biopharma, Inc. Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
US9111624B2 (en) 2013-03-22 2015-08-18 Katsuyuki Fujita Semiconductor memory device

Similar Documents

Publication Publication Date Title
JP2006516098A5 (https=)
JP2007508034A5 (https=)
JP2003515323A5 (https=)
IL164966A0 (en) 3?-Ä2Z)-Ä1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylideneÜhydrazinoÜ-2'-hydroxy-Ä1,1'-biphenylÜ-3-carboxylic acid bis-(monoethanolamine)
WO2003093296A3 (en) Kinase anchor protein muteins, peptides thereof, and related methods
WO2003093306A3 (en) Nucleic acids and proteins from streptococcus groups a & b
EP1085089A3 (en) Human cyclic nucleotide phosphodiesterase
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
EP1628535A4 (en) CELL SPECIFIC REPLICATION COMPETENT VIRUS VECTORS WITH SELF-PROCESSING PEPTIDE SPLICE
JP2005530695A5 (https=)
AU2003304180A8 (en) Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
JP2002540769A5 (https=)
CA2361987A1 (en) Goodpasture antigen binding protein
IS7609A (is) 2,5-tvíútskipt 3-merkaptópentansýra
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
JP2003284553A5 (https=)
AU2003223923A8 (en) Peptide nucleic acid conjugates with transporter peptides
JP2006515984A5 (https=)
JP2005535281A5 (https=)
EP1585760A4 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES BTL-II
JP2006510360A5 (https=)
ATE484582T1 (de) Aus koji-schimmelpilz stammende phospholipase a2
JPH10210974A5 (https=)
AU2003216772A1 (en) Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof
RU2002110800A (ru) Искусственный белок-иммуноген TCI, содержащий множественные CTL-эпитопы основных антигенов ВИЧ-1, искусственный ген TCI, кодирующий полиэпитопный белок-иммуноген TCI